AtaiBeckley Inc. (NASDAQ: ATAI) announced the Food and Drug Administration has indicated support for the company's proposed Phase 3 program ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE